CD3 binding antibodies
The present invention relates to novel human CD3 antigen binding polypeptides and their preparation and use in the treatment and/or diagnosis of various diseases, and also to bispecific antibody molecules capable of activating immune effector cells and their use in the diagnosis and/or treatment of...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TRINKLEIN NATHAN VANSCHOOTEN WIM PALM, DAVID HARRIS KATHERINE ALDRED SHELLEY FORCE |
| description | The present invention relates to novel human CD3 antigen binding polypeptides and their preparation and use in the treatment and/or diagnosis of various diseases, and also to bispecific antibody molecules capable of activating immune effector cells and their use in the diagnosis and/or treatment of various diseases.
本发明涉及新的人CD3抗原结合多肽以及其制备和在各种疾病的治疗和/或诊断中的用途，并且还涉及能够活化免疫效应细胞的双特异性抗体分子以及其在各种疾病的诊断和/或治疗中的用途。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN117603353A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN117603353A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN117603353A3</originalsourceid><addsrcrecordid>eNrjZBBzdjFWSMrMS8nMS1dIzCvJTMpPyUwt5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hobmZgbGxqbGjsbEqAEAYgwg7g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CD3 binding antibodies</title><source>esp@cenet</source><creator>TRINKLEIN NATHAN ; VANSCHOOTEN WIM ; PALM, DAVID ; HARRIS KATHERINE ; ALDRED SHELLEY FORCE</creator><creatorcontrib>TRINKLEIN NATHAN ; VANSCHOOTEN WIM ; PALM, DAVID ; HARRIS KATHERINE ; ALDRED SHELLEY FORCE</creatorcontrib><description>The present invention relates to novel human CD3 antigen binding polypeptides and their preparation and use in the treatment and/or diagnosis of various diseases, and also to bispecific antibody molecules capable of activating immune effector cells and their use in the diagnosis and/or treatment of various diseases.
本发明涉及新的人CD3抗原结合多肽以及其制备和在各种疾病的治疗和/或诊断中的用途，并且还涉及能够活化免疫效应细胞的双特异性抗体分子以及其在各种疾病的诊断和/或治疗中的用途。</description><language>chi ; eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240227&DB=EPODOC&CC=CN&NR=117603353A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240227&DB=EPODOC&CC=CN&NR=117603353A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TRINKLEIN NATHAN</creatorcontrib><creatorcontrib>VANSCHOOTEN WIM</creatorcontrib><creatorcontrib>PALM, DAVID</creatorcontrib><creatorcontrib>HARRIS KATHERINE</creatorcontrib><creatorcontrib>ALDRED SHELLEY FORCE</creatorcontrib><title>CD3 binding antibodies</title><description>The present invention relates to novel human CD3 antigen binding polypeptides and their preparation and use in the treatment and/or diagnosis of various diseases, and also to bispecific antibody molecules capable of activating immune effector cells and their use in the diagnosis and/or treatment of various diseases.
本发明涉及新的人CD3抗原结合多肽以及其制备和在各种疾病的治疗和/或诊断中的用途，并且还涉及能够活化免疫效应细胞的双特异性抗体分子以及其在各种疾病的诊断和/或治疗中的用途。</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBBzdjFWSMrMS8nMS1dIzCvJTMpPyUwt5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hobmZgbGxqbGjsbEqAEAYgwg7g</recordid><startdate>20240227</startdate><enddate>20240227</enddate><creator>TRINKLEIN NATHAN</creator><creator>VANSCHOOTEN WIM</creator><creator>PALM, DAVID</creator><creator>HARRIS KATHERINE</creator><creator>ALDRED SHELLEY FORCE</creator><scope>EVB</scope></search><sort><creationdate>20240227</creationdate><title>CD3 binding antibodies</title><author>TRINKLEIN NATHAN ; VANSCHOOTEN WIM ; PALM, DAVID ; HARRIS KATHERINE ; ALDRED SHELLEY FORCE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN117603353A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>TRINKLEIN NATHAN</creatorcontrib><creatorcontrib>VANSCHOOTEN WIM</creatorcontrib><creatorcontrib>PALM, DAVID</creatorcontrib><creatorcontrib>HARRIS KATHERINE</creatorcontrib><creatorcontrib>ALDRED SHELLEY FORCE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TRINKLEIN NATHAN</au><au>VANSCHOOTEN WIM</au><au>PALM, DAVID</au><au>HARRIS KATHERINE</au><au>ALDRED SHELLEY FORCE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CD3 binding antibodies</title><date>2024-02-27</date><risdate>2024</risdate><abstract>The present invention relates to novel human CD3 antigen binding polypeptides and their preparation and use in the treatment and/or diagnosis of various diseases, and also to bispecific antibody molecules capable of activating immune effector cells and their use in the diagnosis and/or treatment of various diseases.
本发明涉及新的人CD3抗原结合多肽以及其制备和在各种疾病的治疗和/或诊断中的用途，并且还涉及能够活化免疫效应细胞的双特异性抗体分子以及其在各种疾病的诊断和/或治疗中的用途。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN117603353A |
| source | esp@cenet |
| subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
| title | CD3 binding antibodies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T23%3A21%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TRINKLEIN%20NATHAN&rft.date=2024-02-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN117603353A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |